Microbiome Program Faculty

Microbial spatial transcriptomics in colorectal cancer

Investigating how gut microbiota and their metabolites regulate host physiology, including immunity, metabolism and the nervous system

The roles of the gut microbiota in metabolic diseases and cancer

Connection between the intestinal microbiome and toxicities associated with hematopoietic stem cell transplant patients

Leveraging multi-omic strategies to define how dietary interventions, metabolic dysfunction and microbiota impact radiation response in the tumor micro-environment with the ultimate goal of identifying new biomarkers and therapeutic strategies in genitourinary and gastrointestinal cancers

Mitigating chemoradiotherapy-induced toxicities in head and neck cancer

Investigating the role of gut and tumor microbiomes in the pathogenesis, progression, and outcomes of pancreatic cancer

Skin microbiome profiling in immunotherapy patients with immune-related cutaneous adverse events

Dietary modulation of the intestinal microbiome to enhance therapeutic outcomes in patients undergoing allogeneic hematopoietic cell transplantation

LFCC

Investigating the role of oral and tumor microbiomes in lung cancer pathogenesis, progression, and outcomes

Deciphering the connection between the intestinal microbiome and hematopoietic stem cell transplant patient outcomes

Targeting the microbiome through dietary modulation in head and neck cancer patients

Defining the impact of the microbiome and its metabolites on patient outcomes following allo-HSCT and CAR T cell therapies

Investigating the role of gut and tumor microbiomes in the pathogenesis, progression, and outcomes of kidney cancer

Defining how gut microbiota composition predicts steroid response in acute gastrointestinal graft-versus-host disease (GVHD)